English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52894262    線上人數 :  759
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 276-285 / 881 (共89頁)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-28T06:46:59Z Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate CHING-HUNG LIN; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; Hong R.-L.
臺大學術典藏 2021-07-26T10:01:35Z Effect of Weighting Strategies on Taguchi-based Optimization of the Four-Stage Constant Current Charge Pattern Lee C;Hsu C;Hsu S;Jiang J.; Lee C; Hsu C; Hsu S; Jiang J.; JOE-AIR JIANG
臺大學術典藏 2021-07-20T03:15:17Z Spectrum of cancer patients receiving renal biopsy Chang F.-C.; Chen T.W.-W.; Huang T.T.-M.; Lin W.-C.; Liu J.-S.; Chiang W.-C.; Chen Y.-M.; Hsu C.; Yeh K.-H.; TZONG-SHINN CHU
臺大學術典藏 2021-07-12T08:46:27Z Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients Chen I.C.; Hsu C.; Chen Y.C.; Chien S.F.; HSIANG-FONG KAO; Chang S.Y.; Hu F.C.; Yeh K.H.
臺大學術典藏 2021-07-12T08:46:26Z Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers HSIANG-FONG KAO; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-07-03T03:35:05Z A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Cheng A.-L.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:56Z Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy Hsu C.; Wei S.-C.; Cheng A.-L.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:50Z Lamivudine and hepatitis B reactivation Hsu C.; Cheng A.-L.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:50Z Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:48Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; PEI-JER CHEN; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.

顯示項目 276-285 / 881 (共89頁)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
每頁顯示[10|25|50]項目